Lead strategic research and development efforts focused on early cancer detection, driving the development of novel computational methods and machine learning models. Oversee the analysis of large and complex genomic datasets, partnering cross-functionally to guide product development. Bring deep expertise in bioinformatics, cancer biology, and statistical modeling, and be capable of leading both scientific and technical contributors.

Responsible for protocol development including study design, sample size calculation, randomization, and statistical analysis plan for assigned studies. Provide statistical oversight to studies and assure adequate quality and consistency with project requirements. Responsible for assuring that data for statistical analyses are complete, accurate and consistent.

Care Access Study Start Up Managers play a critical role in facilitating the start-up activities needed to select and activate studies at sites within Care Access. This role supports the selection and start-up process for our sites by leading cross-functional groups across the global organization to complete successful pre-site visits and accelerate site activation.

The Sr. Director, Clinical Operations is a senior leadership role focused on advancing the company’s mission to develop innovative cell therapies for autoimmune diseases. This position involves leading the operational strategy and delivery of clinical programs, ensuring alignment with corporate goals. This individual will act as a role model for Kyverna’s core values and will be responsible for leading and participating in initiatives for process, technology or other continuous improvement.

Develop and pioneer optical approaches from concept to a working breadboard prototype to further iLoF's mission in personalised medicine. Work closely with data scientists and bioclinicians to develop technologies that are aligned with customer requirements. Analyse and interpret experimental data to ensure that practical implementations of approaches align with performance goals.

The Senior Translational Medical Scientist plays a key role in advancing Natera’s oncology pipeline by partnering with clinicians, product managers, and key opinion leaders (KOLs) to apply genomic data in improving healthcare outcomes. This role primarily supports the development of products for early cancer detection, with secondary responsibilities that include participation in translational initiatives aimed at optimizing circulating tumor DNA (ctDNA) testing and informing clinical decision-making in both solid and hematologic malignancies.

Drive statistical innovation, ensuring methodological rigor and enhanced decision making across diverse projects. Expertise in cutting-edge design and analysis techniques will be instrumental in optimizing drug development outcomes. Collaborate with multidisciplinary teams, mentor statisticians and epidemiologists, and represent our organization in key cross-industry initiatives, making a meaningful impact on drug development.

We are seeking a dynamic and experienced Program Director to lead and oversee our health screening and research study programs. The Program Director will be responsible for managing multiple projects, ensuring the successful launch of new programs, and fostering collaboration among interdisciplinary teams. This role requires a strategic thinker with excellent leadership skills and a strong background in clinical research.

Ensures accurate and consistent coding of medical data, including but not limited to, adverse events and medication data received from global clinical trials across all therapeutic areas as part of the Global Coding Team (GCT). Primary coding resource for assigned studies and serves as subject matter expert to study team members and other key stakeholders. Accurately code clinical trial data using MedDRA and WHODrug in accordance with company conventions.

Apply your scientific expertise to the development of early, noninvasive tests for cancer detection. With a strong background in NGS assay development, bioinformatics, statistics, and molecular biology, you will design and execute research studies to drive early research of prototype cancer early detection products using cfDNA as biomarker. In collaboration with wet lab scientists, rapidly characterize and iterate on experimental methods by providing real-time assessments of assay performance, quality control, and clinical/diagnostic utility.